Royal Bank of Canada
IBDX icon

Royal Bank of Canada’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Royal Bank of Canada’s Portfolio IBDX Stock Details IBDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.7M Buy
1,017,649
+26,911
+3% +$687K ﹤0.01% 1280
2025
Q4 		$25.3M Buy
990,738
+621,972
+169% +$15.9M ﹤0.01% 1334
2025
Q3 		$9.45M Buy
368,766
+19,728
+6% +$501K ﹤0.01% 2193
2025
Q2 		$8.83M Sell
349,038
-15,113
-4% -$375K ﹤0.01% 2116
2025
Q1 		$9.1M Buy
364,151
+6,362
+2% +$157K ﹤0.01% 1815
2024
Q4 		$8.79M Buy
357,789
+7,493
+2% +$188K ﹤0.01% 1883
2024
Q3 		$9.01M Buy
350,296
+47,709
+16% +$1.2M ﹤0.01% 1845
2024
Q2 		$7.43M Sell
302,587
-136,266
-31% -$3.33M ﹤0.01% 1879
2024
Q1 		$10.9M Buy
438,853
+298,019
+212% +$7.38M ﹤0.01% 1629
2023
Q4 		$3.55M Buy
140,834
+86,232
+158% +$2.06M ﹤0.01% 2543
2023
Q3 		$1.28M Buy
54,602
+1,845
+3% +$44.5K ﹤0.01% 3235
2023
Q2 		$1.3M Buy
52,757
+4,902
+10% +$121K ﹤0.01% 3164
2023
Q1 		$1.2M Buy
47,855
+47,518
+14,100% +$1.18M ﹤0.01% 3214
2022
Q4 		$8K Buy
+337
New +$8.09K ﹤0.01% 6611

Other funds holding IBDX

ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $1.89B AUM 14.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KA
Klingman & Associates New York $2.09B AUM 16.49% 1-Year Est. Return

Royal Bank of Canada's IBDX Position: Q1 2026 in Review

Royal Bank of Canada increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 2.7% in Q1 2026, buying an estimated $687K and bringing the position to 1,017,649 shares worth $25.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Royal Bank of Canada first reported a position in IBDX in Q4 2022 and has held it in 14 quarters since. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • Royal Bank of Canada held 1,017,649 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $25.7M as of Q1 2026.
  • Royal Bank of Canada bought 26,911 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $687K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1280 holding.
  • Royal Bank of Canada first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2022 and has held it in 14 quarters since.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.